Altimmune
ALT
33 hedge funds and large institutions have $52.6M invested in Altimmune in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
38% more capital invested
Capital invested by funds: $38M → $52.6M (+$14.6M)
3% more funds holding
Funds holding: 32 → 33 (+1)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIM
26
BlackRock Investment Management
Wilmington,
Delaware
| $19K | +$1.5K | +3 | +10% |
|
|
LTFS
27
Ladenburg Thalmann Financial Services
Miami,
Florida
| $17K | – | – | – |
|
28
Group One Trading
Chicago,
Illinois
| $8K | -$3.49K | -7 | -32% |
|
29
UBS Group
Zurich,
Switzerland
| $5K | +$3.49K | +7 | +700% |
|
30
Morgan Stanley
New York
| $4K | – | – | – |
|
31
Citigroup
New York
| $2K | -$1.5K | -3 | -43% |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | -$499 | -1 | -25% |
|
33
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $5 | – | – | – |
|
34
Fidelity Investments
Boston,
Massachusetts
| – | -$431K | -1,081 | Closed |
|
|
LYV
35
Live Your Vision
West Conshohocken,
Pennsylvania
| – | -$10K | -26 | Closed |
|
ALT Hedge Fund Activity: Q4 2015 in Review
33 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2015, worth a combined $52.6M — up 38% from $38M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ALT positions and 2 closed out — a net gain of 2 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $870K. The largest seller was Hudson Bay Capital Management, cutting an estimated $1.21M.
- 33 institutional investors held Altimmune (ALT) as of Q4 2015, up from 32 in Q3 2015.
- Funds reported $52.6M of Altimmune stock for Q4 2015, up 38% quarter-over-quarter.
- 4 funds opened new Altimmune positions in Q4 2015 and 2 closed out, a net change of +2 holders.
- The largest Altimmune buyer in Q4 2015 was Nantahala Capital Management, an estimated $870K added.
- The largest Altimmune seller in Q4 2015 was Hudson Bay Capital Management, an estimated $1.21M sold.
Based on aggregated 13F filings for Q4 2015.